Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Archives of Pathology & Laboratory Medicine|April 24, 2003
Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patientsSarfraz Ahmad, H Peter Bacher, Michael R Lassen, et al.
Chest|September 24, 2004
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyWilliam H Geerts, Graham F Pineo, John A Heit, et al.
The New England Journal of Medicine|June 27, 2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplastyMichael R Lassen, Walter Ageno, Lars C Borris, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Thrombosis and Haemostasis|October 19, 2013
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)Bengt I Eriksson, Giancarlo Agnelli, Alexander S Gallus, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 14, 2014
Sustained release of tissue factor following thrombosis of lower limb traumaJeanine M Walenga, Phoebe C Kaiser, M Margaret Prechel, et al.
Thrombosis Research|May 18, 2013
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verificationFredrik Wexels, Anniken Haslund, Ola E Dahl, et al.
Thrombosis Research|May 15, 2014
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolismFredrik Wexels, Ola E Dahl, Are H Pripp, et al.
Annals of Surgery|December 31, 2013
Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trialAjay K Kakkar, Giancarlo Agnelli, William Fisher, et al.
The New England Journal of Medicine|February 17, 2012
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancerGiancarlo Agnelli, Daniel J George, Ajay K Kakkar, et al.
Pageof 4